Named on one round in the feed.
Since 2025-03-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
4C Medical Minimally invasive technologies for treating structural heart diseases, specifically for mitral regurgitation. | Series D+ Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2025-03-05 | [ LEAD ] |
No one else named on these rounds.
No sector on record.